The Watanabe heritable hyperlipidemic (WHHL) rabbit has a genetic defect in the low density lipoprotein (LDL) receptor. Rabbits homozygous for this defect exhibit spontaneous hyperlipidemia on a low fat diet, atherosclerosis, tendon xanthomas, a markedly decreased number of LDL receptors in several tissues, and impaired LDL catabolism in vivo. Therefore there are striking similarities between this animal model and the human disease, Familial Hypercholesterolemia. The long term objective of this project is to explore the derrangements in lipoprotein metabolism that result from an LDL receptor deficiency in the WHHL rabbit. Alterations in lipoprotein composition resulting from this genetic defect will first be defined. Using radiolabeled lipoproteins, derrangements in lipoprotein metabolism will be studied in an attempt to understand the pathogenesis of the hyperlipidemia. Radiolabeled LDL will be used to study alterations in tissue uptake of this lipoprotein in the absence of functioning LDL receptors. This approach will also be used to better define the role of the reticuloendothelial system (RES) in LDL catabolism when LDL receptors are not present. Finally, the impact of the LDL receptor deficiency on total body cholesterol metabolism will be explored using standard cholesterol balance techniques. Since an LDL receptor deficiency state is associated with hyperlipidemia and spontaneous atherosclerosis in two species as different as the rabbit and the human, a delineation of the lipoprotein abnormalities resulting from this receptor defect in the rabbit should enhance our understanding of similar factors contributing to atherosclerosis in the human.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL015949-12
Application #
3335071
Study Section
Metabolism Study Section (MET)
Project Start
1976-12-01
Project End
1988-03-31
Budget Start
1985-04-01
Budget End
1986-03-31
Support Year
12
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Bilheimer, D W (1989) Portacaval shunt and liver transplantation in treatment of familial hypercholesterolemia. Arteriosclerosis 9:I158-63
Bilheimer, D W (1988) Metabolic effects of portacaval shunt surgery and liver transplantation in familial hypercholesterolemia. Beitr Infusionsther 23:61-73
Bilheimer, D W (1988) Portacaval shunt surgery and liver transplantation in the treatment of homozygous familial hypercholesterolemia. Prog Clin Biol Res 255:295-304
Bilheimer, D W (1988) Metabolic effects of portacaval shunt surgery and liver transplantation in familial hypercholesterolemia. Beitr Infusionsther 23:61-73
Bilheimer, D W; Grundy, S M (1987) The role of the LDL receptor in lipoprotein metabolism. Adv Exp Med Biol 210:123-30
Spady, D K; Huettinger, M; Bilheimer, D W et al. (1987) Role of receptor-independent low density lipoprotein transport in the maintenance of tissue cholesterol balance in the normal and WHHL rabbit. J Lipid Res 28:32-41
Ma, P T; Gil, G; Sudhof, T C et al. (1986) Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits. Proc Natl Acad Sci U S A 83:8370-4
East, C; Grundy, S M; Bilheimer, D W (1986) Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation. JAMA 256:2843-8
Bilheimer, D W (1986) Lipoprotein fractions and receptors: a role for probucol? Am J Cardiol 57:7H-15H
Dunn, F L; Grundy, S M; Bilheimer, D W et al. (1985) Impaired catabolism of very low-density lipoprotein-triglyceride in a family with primary hypertriglyceridemia. Metabolism 34:316-24

Showing the most recent 10 out of 11 publications